PharmaCyte Biotech, Inc.
USD0.75
-0.05 (-6.11%)
CEO
Joshua N. Silverman
IPO Date
2013-01-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.78
Prev. Close
$0.80
Day Low
$0.75
Day High
$0.81
52W Low
$0.63
52W High
$1.51
Market Cap
$0.01B
Volume
0.13M
| 119,170 |
| $0.67 |
| 2 Apr 2026 | SCHECHTER JONATHAN | director | A-Award | Acquired | 119,170 | $0.67 |
| 2 Apr 2026 | Abecassis Michael M | director | A-Award | Acquired | 119,170 | $0.67 |
| 7 Jan 2026 | Silverman Joshua | director, officer: CEO and President | P-Purchase | Acquired | 30,000 | $0.78 |
| 7 Jan 2026 | Silverman Joshua | director, officer: CEO and President | P-Purchase | Acquired | 30,000 | $0.79 |
| 7 Jan 2026 | Silverman Joshua | director, officer: CEO and President | P-Purchase | Acquired | 40,000 | $0.83 |
| 7 Jan 2026 | SCHECHTER JONATHAN | director | P-Purchase | Acquired | 20,000 | $0.78 |
| 7 Jan 2026 | SCHECHTER JONATHAN | director | P-Purchase | Acquired | 20,000 | $0.79 |
| 7 Jan 2026 | SCHECHTER JONATHAN | director | P-Purchase | Acquired | 20,000 | $0.84 |